- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04576286
Holmium Versus Bipolar en Bloc Transurethral Resection of Urothelium Tumor of the Urinary Bladder
Holmium Versus Bipolar en Bloc Transurethral Resection of Urothelium Tumor of the Urinary Bladder: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Modern laser technology has led to new alternatives to conventional TURBT (cTURBT). The advocates of ERBT have three goals: to improve resection quality, lower perioperative complication rates, and decrease recurrence rates at resection sites. The present study is the first to compare the results of laser and electric en bloc resection of bladder cancer with respect to the aforementioned goals.
the investigators aim to compare the clinical outcome in the form of safety and efficacy between Holmium and bipolar transurethral en bloc resection of urinary bladder tumors.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt, 11361
- Ain Shams University Hospitals
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult patients of both sexes presented with urinary bladder tumor aiming for complete resection as diagnosed by Ultrasound with or without CT prior histopathological assessment.
Exclusion Criteria:
- Patients with signs of extravesical tumor extension where complete resection will not beneficial or unable to proceed to complete resection due to huge tumor burden either huge single tumor more than 5 cm or multiple tumors that are not candidate for complete resection.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Holmium en bloc resection
Holmium en bloc resection procedure will be done under either general or spinal anesthesia, using a Holmium laser device (Cyber Ho, Quanta device, Milano, Italy).
We will use a 30-40-watt power, 1-2 joules and 20-30 MHz frequency
|
After obtaining informed consent, patients will be randomized with a 1:1 ratio using sealed envelopes that will be prepared by the department's ethical committee into 2 groups, group 1 represent the Holmium en bloc resection procedure while group 2 represents bipolar en bloc resection. Patients will be blinded to the type of intervention as well as the data collector and the statistician. Intervention: all procedures will be done by an expert surgeon who performed over 50 cases of en bloc urinary bladder tumor resection with each energy source. In group A, Holmium en bloc resection procedure will be done under either general or spinal anesthesia, using a Holmium laser device (Cyber Ho, Quanta device, Milano, Italy). We will use a 30-40-watt power, 1-2 joules and 20-30 MHz frequency for Group A and bipolar en bloc resection for Group B. A 550 nm flexible laser fiber will be used in group A and a bipolar resection loop for group B. |
|
Active Comparator: bipolar en bloc resection
bipolar en bloc tumor resection of urinary bladder tumors
|
After obtaining informed consent, patients will be randomized with a 1:1 ratio using sealed envelopes that will be prepared by the department's ethical committee into 2 groups, group 1 represent the Holmium en bloc resection procedure while group 2 represents bipolar en bloc resection. Patients will be blinded to the type of intervention as well as the data collector and the statistician. Intervention: all procedures will be done by an expert surgeon who performed over 50 cases of en bloc urinary bladder tumor resection with each energy source. In group A, Holmium en bloc resection procedure will be done under either general or spinal anesthesia, using a Holmium laser device (Cyber Ho, Quanta device, Milano, Italy). We will use a 30-40-watt power, 1-2 joules and 20-30 MHz frequency for Group A and bipolar en bloc resection for Group B. A 550 nm flexible laser fiber will be used in group A and a bipolar resection loop for group B. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
number of participant with Conversion to the TURBT
Time Frame: intraoperative finding
|
conversion from the enbloc way of resection to the standard trans-urethral resection of bladder tumors
|
intraoperative finding
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Operative time
Time Frame: intraoperative finding
|
calculation of operative time in minutes
|
intraoperative finding
|
|
Presence of detrusor muscle in resected sample
Time Frame: one day after surgery during pathological evaluation
|
presence of muscle layer in the pathological specimen (Yes/No)
|
one day after surgery during pathological evaluation
|
|
Resected specimen's edge
Time Frame: one day after surgery during pathological evaluation
|
tumor free margin (Yes/No)
|
one day after surgery during pathological evaluation
|
|
intraoperative complication: bladder perforation
Time Frame: intraoperative
|
(Yes/No) bladder perforation
|
intraoperative
|
|
Incidence of obturator reflex
Time Frame: intraoperative
|
(Yes/No) energy induced obturator reflex
|
intraoperative
|
|
hematuria
Time Frame: postoperative complication up to 2 weeks
|
(Yes/No)
|
postoperative complication up to 2 weeks
|
|
Post-operative catheterization time in hours
Time Frame: postoperative complication up to 2 weeks
|
time till catheter removal in days
|
postoperative complication up to 2 weeks
|
|
Postoperative irrigation time in hours
Time Frame: postoperative in hours maximum 1 day
|
hours for the need of postoperative irrigation
|
postoperative in hours maximum 1 day
|
|
Recurrence rate of tumors according to time interval
Time Frame: 1 year
|
recurrence of tumor in the follow up cystoscopy
|
1 year
|
|
Recurrence rate of tumors according to tumor location
Time Frame: 1 year
|
recurrence of tumor in the follow up cystoscopy in the same site or in different site
|
1 year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FMASU R32/2020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Bladder Neoplasm
-
Ikena OncologyBristol-Myers SquibbCompletedNeoplasms | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Bladder Cancer | Advanced Solid Tumor | Advanced Cancer | Urothelial Carcinoma Bladder | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | Bladder Disease | Solid Carcinoma | Neoplasm Malignant | Neoplasm, Bladder | Locally Advanced... and other conditionsUnited States
-
GlaxoSmithKlineCompletedNeoplasms, Urinary BladderBelgium
-
Mansoura UniversityCompletedBladder Cancer | Bladder Disease | Bladder Neoplasm | Micro-RNAEgypt
-
Benha UniversityRecruiting
-
Ziv HospitalNot yet recruitingBladder Neoplasm
-
Ziv HospitalAzrieli Faculty of medicine, Bar Ilan University, Safed, ILNot yet recruitingBladder Neoplasm
-
Betul KartalBağcılar Eğitim ve Araştırma HastanesiRecruiting
-
Diskapi Teaching and Research HospitalCompleted
-
Mansoura UniversityUnknown
-
Lille Catholic UniversityCompletedUrinary Bladder NeoplasmFrance
Clinical Trials on Holmium versus Bipolar en bloc transurethral resection
-
Chinese University of Hong KongThe University of Hong Kong; Queen Elizabeth Hospital, Hong Kong; North District... and other collaboratorsCompleted
-
Betul KartalBağcılar Eğitim ve Araştırma HastanesiRecruiting
-
Chinese University of Hong KongRecruitingBladder Cancer | Bladder Tumor | Bladder NeoplasmHong Kong
-
Beni-Suef UniversityCompleted
-
Tongji HospitalUnknownNon-muscle Invasive Bladder Cancer
-
Lahore General HospitalCompletedUrinary Bladder Neoplasms | Non-muscle Invasive Bladder CancerPakistan
-
Fundacio PuigvertKARL STORZ Endoscopy-America, Inc.RecruitingBladder Cancer | Urothelial Carcinoma BladderSpain
-
Benha UniversityRecruiting
-
Menoufia UniversityRecruitingBipolar TURP , Laser Enucleation in Management of Enlarged ProstateEgypt
-
Shanghai General Hospital, Shanghai Jiao Tong University...Unknown